MI/26/24 Group Leader/Senior Group Leader for Immunology

Key Details

Job ID:
MI/26/24
Role:
Group Leader/Senior Group Leader for Immunology
Salary:
£61,944 – £81,508* per annum (Group Leader) or £80,000 – £130,000* per annum (Senior Group Leader)
Closing date:
2nd August 2026

About the role

The Cancer Research UK Manchester Institute (CRUK MI) is seeking exceptional early-career and senior scientists, including clinician scientists, to establish bold and innovative research programmes as independent Group Leaders.

Situated within one of Europe’s largest and most dynamic cancer research ecosystems, successful candidates will join an outstanding collaborative environment spanning the Cancer Research UK Manchester Institute, the Manchester Cancer Research Centre (MCRC), The University of Manchester, the Lydia Becker Institute of Immunology and Inflammation, the MRC Centre of Research Excellence in Exposome Immunology, and The Christie NHS Foundation Trust.

This unique ecosystem integrates fundamental immunology, cancer biology, computational science, experimental medicine and clinical translation, creating exceptional opportunities to pursue high-impact discovery research while accelerating the development of new immunotherapies, biomarkers and advanced cellular and genetic therapies for patients with cancer.

About you

We are seeking applicants with expertise in cancer immunology, including anti-tumour immunity, immunotherapy, inflammation, stromal and immune interactions within the tumour microenvironment, advanced therapeutic approaches, and systems and computational immunology. We particularly welcome ambitious and innovative research programmes that combine technical excellence and interdisciplinary approaches to address fundamental and translational questions in cancer biology and strengthen our internationally recognised research environment in cancer immunology and immuno-oncology.

Scientific image showcasing research findings on cell interactions
Histological section of gut tissue with detailed cellular structures visible under a microscope

How to apply

How to apply

To apply for this position please complete the online application via the links below before 02 August 2026, Sunday (British Summer Time).

Applications should include:
· Cover Letter
· Curriculum Vitae including publication list
· Future Research Plan (maximum three pages)
· Summary of up to three key publications (maximum one page)
· Contact details for three referees

Informal enquiries are welcomed and may be addressed to any of the Institute’s Group Leaders or to the Director: director@cruk.manchester.ac.uk

Please note this vacancy will close for applications at 18:00 hours on the closing date specified.

Further particulars about the role

Find everything you need to know about this vacancy.

How to apply
Further particulars about the role

Translation and Clinical Impact in Manchester

A defining strength of Manchester is the close integration of discovery science with clinical research and patient care.

Through partnership with The Christie NHS Foundation Trust, one of Europe’s largest comprehensive cancer centres, successful candidates will have access to exceptional opportunities for translational and clinical research. These include experimental medicine programmes, window-of-opportunity studies, biomarker-led clinical trials, advanced therapy development and early-phase clinical studies.

Manchester provides a uniquely integrated environment for researchers interested in translating discoveries in tumour immunology into novel therapeutic approaches, including cellular therapies, immune engineering, in vivo genetic engineering, immunomodulatory biologics and precision immunotherapy strategies. The close interaction between discovery scientists, clinician scientists, translational researchers and trialists creates an outstanding platform for moving innovative concepts rapidly from laboratory investigation to patient benefit.

Researchers will also benefit from access to major strategic initiatives across the Manchester ecosystem, including:

  • MANIFEST, the national Manchester platform for immunotherapy research and innovation.
  • RISE, a multidisciplinary programme developing next-generation approaches to reduce immune stress and cytokine release associated with advanced therapies.
  • The MRC Centre of Research Excellence in Exposome Immunology, which is establishing internationally leading capabilities for understanding how environmental exposures shape immune function across health and disease.

Together, these initiatives provide unique opportunities to pursue collaborative and interdisciplinary research at scale.

Our experimental base, equipped with the latest pre-clinical testing platforms, located alongside the largest single-site cancer hospital in Europe, and forming part of a powerful Manchester immunology community, is well-placed to be the source of the next great leaps ahead in cancer immunology.

Professor Samra Turajlić

Director, Cancer Research UK Manchester Institute

Photograph of Professor Samra Turajlić
Professor Samra Turajlić
GARP
The Paterson Building as seen from Maggies Centre

More information

The power of immunology in Manchester

CRUK Manchester Institute has established internationally recognised strengths in cancer immunology and immuno-oncology, including tumour immune regulation, mechanisms of anti-tumour immunity, immunotherapy resistance, tumour microenvironment biology, inflammatory cell death and tissue adaptation. Successful candidates will join a vibrant and highly collaborative immunology community and will have opportunities to interact closely with leading investigators across the Manchester ecosystem, including groups led by Santiago Zelenay, Evangelos Giampazolias, Jonathan Lim and colleagues across the Lydia Becker Institute and the MRC Centre of Research Excellence in Exposome Immunology.

About CRUK Manchester Institute

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials. The Institute has access to outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.

The power of immunology in Manchester
About CRUK Manchester Institute